Furfenorex

Furfenorex
Clinical data
ATC code
  • none
Identifiers
  • (RS)-N-(furan-2-ylmethyl)-N-methyl-1-phenylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H19NO
Molar mass229.323 g·mol−1
3D model (JSmol)
  • o1c(ccc1)CN(C(C)Cc2ccccc2)C
  • InChI=1S/C15H19NO/c1-13(11-14-7-4-3-5-8-14)16(2)12-15-9-6-10-17-15/h3-10,13H,11-12H2,1-2H3 checkY
  • Key:DLGIIZAHQPTVCJ-UHFFFAOYSA-N checkY
  (verify)

Furfenorex (Frugalan), also known as furfurylmethylamphetamine, is a stimulant drug which was developed in the 1960s and used as an appetite suppressant.[1] It produces methamphetamine as a metabolite,[2] and has been withdrawn from the market due to abuse potential.[3]

  1. ^ Boissier JR, Dumont C, Ratouis R, Moisy D (May 1967). "[Pharmacologic study of an anorexigenic agent: furfenorex]". Archives Internationales de Pharmacodynamie et de Thérapie. 167 (1): 150–62. PMID 6035092.
  2. ^ Marsel J, Döring G, Remberg G, Spiteller G (1972). "[Methamphetamine--a metabolite of the anorectics Benzphetamine and Furfenorex]". Zeitschrift für Rechtsmedizin. Journal of Legal Medicine. 70 (4): 245–50. doi:10.1007/BF02079690. PMID 5084766. S2CID 32585009.
  3. ^ Daspaguta A (March 2009). A Health Educator's Guide to Understanding Drugs of Abuse Testing (1 ed.). Sudbury, Massachusetts: Jones & Bartlett Publishers. ISBN 9780763765897. Retrieved 11 December 2019.